These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 32024292)

  • 1. Engineering Biology to Construct Microbial Chassis for the Production of Difficult-to-Express Proteins.
    Kim K; Choe D; Lee DH; Cho BK
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chasing bacterial chassis for metabolic engineering: a perspective review from classical to non-traditional microorganisms.
    Calero P; Nikel PI
    Microb Biotechnol; 2019 Jan; 12(1):98-124. PubMed ID: 29926529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrosynthetic design of heterologous pathways.
    Carbonell P; Planson AG; Faulon JL
    Methods Mol Biol; 2013; 985():149-73. PubMed ID: 23417804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streamlining genomes: toward the generation of simplified and stabilized microbial systems.
    Leprince A; van Passel MW; dos Santos VA
    Curr Opin Biotechnol; 2012 Oct; 23(5):651-8. PubMed ID: 22651991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prototyping of microbial chassis for the biomanufacturing of high-value chemical targets.
    Robinson CJ; Tellechea-Luzardo J; Carbonell P; Jervis AJ; Yan C; Hollywood KA; Dunstan MS; Currin A; Takano E; Scrutton NS
    Biochem Soc Trans; 2021 Jun; 49(3):1055-1063. PubMed ID: 34100907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial cell factories based on filamentous bacteria, yeasts, and fungi.
    Ding Q; Ye C
    Microb Cell Fact; 2023 Jan; 22(1):20. PubMed ID: 36717860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new strategies to overcome challenges in protein production in bacteria.
    Lipońska A; Ousalem F; Aalberts DP; Hunt JF; Boël G
    Microb Biotechnol; 2019 Jan; 12(1):44-47. PubMed ID: 30484965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole synthetic pathway engineering of recombinant protein production.
    Brown AJ; Gibson SJ; Hatton D; Arnall CL; James DC
    Biotechnol Bioeng; 2019 Feb; 116(2):375-387. PubMed ID: 30345502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chassis engineering for microbial production of chemicals: from natural microbes to synthetic organisms.
    Liu J; Wu X; Yao M; Xiao W; Zha J
    Curr Opin Biotechnol; 2020 Dec; 66():105-112. PubMed ID: 32738762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Road to the future of systems biotechnology: CRISPR-Cas-mediated metabolic engineering for recombinant protein production.
    Roointan A; Morowvat MH
    Biotechnol Genet Eng Rev; 2016; 32(1-2):74-91. PubMed ID: 28052722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the first drop to the first truckload: commercialization of microbial processes for renewable chemicals.
    Van Dien S
    Curr Opin Biotechnol; 2013 Dec; 24(6):1061-8. PubMed ID: 23537815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems Metabolic Engineering Strategies: Integrating Systems and Synthetic Biology with Metabolic Engineering.
    Choi KR; Jang WD; Yang D; Cho JS; Park D; Lee SY
    Trends Biotechnol; 2019 Aug; 37(8):817-837. PubMed ID: 30737009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plastid genome as a chassis for synthetic biology-enabled metabolic engineering: players in gene expression.
    Schindel HS; Piatek AA; Stewart CN; Lenaghan SC
    Plant Cell Rep; 2018 Oct; 37(10):1419-1429. PubMed ID: 30039465
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Hwang S; Lee Y; Kim JH; Kim G; Kim H; Kim W; Cho S; Palsson BO; Cho BK
    Front Bioeng Biotechnol; 2021; 9():804295. PubMed ID: 34993191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A.
    Unzueta U; Vázquez F; Accardi G; Mendoza R; Toledo-Rubio V; Giuliani M; Sannino F; Parrilli E; Abasolo I; Schwartz S; Tutino ML; Villaverde A; Corchero JL; Ferrer-Miralles N
    Appl Microbiol Biotechnol; 2015 Jul; 99(14):5863-74. PubMed ID: 25616525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria. Biotechnology Bioengineering, 1990.
    Bentley WE; Mirjalili N; Andersen DC; Davis RH; Kompala DS
    Biotechnol Bioeng; 2009 Apr; 102(5):1284-97; discussion 1283. PubMed ID: 19215036
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploring the potential of Saccharomyces cerevisiae for biopharmaceutical protein production.
    Wang G; Huang M; Nielsen J
    Curr Opin Biotechnol; 2017 Dec; 48():77-84. PubMed ID: 28410475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in engineering sustainable biochemical synthesis through microbial systems.
    Song Y; Prather KLJ
    Curr Opin Chem Biol; 2024 Aug; 81():102493. PubMed ID: 38971129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Engineering and Synthetic Biology.
    Ramzi AB
    Adv Exp Med Biol; 2018; 1102():81-95. PubMed ID: 30382570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.